SEARCH

SEARCH BY CITATION

Current Awareness

  • 1. Reviews
  • Chun HJ, Wilson KO, Huang M, Wu JC. Integration of genomics, proteomics, and imaging for cardiac stem cell therapy. Eur J Nucl Med Mol Imaging 34, S20-S26 (2007)
  • Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jager K, Jong N, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsoe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008. Ultraschall Med 29, 28-44 (2008)
  • Culver J, Akers W, Achilefu S. Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med 49, 169-172 (2008)
  • De Leon-Rodriguez LM, Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconjug Chem 19, 391-402 (2008)
  • Fani M, Andre JP, Maecke HR. 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 3, 53-63 (2008)
  • Hartung D, Schafers M, Fujimoto S, Levkau B, Narula N, Kopka K, Virmani R, Reutelingsperger C, Hofstra L, Kolodgie FD, Petrov A, Narula J. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions. Eur J Nucl Med Mol Imaging 34, S1-S8 (2007)
  • Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: Ready for prime time?. Eur Heart J 29, 299-314 (2008)
  • Hezinger AFE, Tessmar J, Gopferich A. Polymer coating of quantum dots - A powerful tool toward diagnostics and sensorics. Eur J Pharm Biopharm 68, 138-152 (2008)
  • Higuchi T, Wester HJ, Schwaiger M. Imaging of angiogenesis in cardiology. Eur J Nucl Med Mol Imaging 34, S9-S19 (2007)
  • Inubushi M, Tamaki N. Radionuclide reporter gene imaging for cardiac gene therapy. Eur J Nucl Med Mol Imaging 34, S27-S33 (2007)
  • Jasanoff A. MRI contrast agents for functional molecular imaging of brain activity. Curr Opin Neurobiol 17, 593-600 (2007)
  • Khondkar S, Fujimoto T, Tashiro M, Itoh M. Imaging assessment of local brain metabolic response to changing load during exercise in humans. Curr Med Imaging Rev 4, 14-18 (2008)
  • Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 94, 360-367 (2008)
  • Kudo T. Metabolic imaging using PET. Eur J Nucl Med Mol Imaging 34, S49-S61 (2007)
  • Kumar R, Dhanpathi H, Basu S, Rubello D, Fanti S, Alavi A. Oncologic PET tracers beyond [18F]FDG and the novel quantitative approaches in PET imaging. Q J Nucl Med Mol Imaging 52, 50-65 (2008)
  • Lamb HJ, Van der Meer RW, De Roos A, Bax JJ. Cardiovascular molecular MR imaging. Eur J Nucl Med Mol Imaging 34, S99-S104 (2007)
  • Lautamaki R, Tipre D, Bengel FM. Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging 34, S74-S85 (2007)
  • Massoud TF, Singh A, Gambhir SS. Noninvasive molecular neuroimaging using reporter genes: Part 1, principles revisited. Am J Neuroradiol 29, 229-234 (2008)
  • Miller DL, Averkiou MA, Brayman AA, Everbach EC, Holland CK, Wible JH, Wu JR. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 27, 611-632 (2008)
  • Mohs AM, Lu ZR. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: Status and clinical potential. Expert Opin Drug Deliv 4, 149-164 (2007)
  • Nimmagadda S, Ford EC, Wong JW, Pomper MG. Targeted molecular imaging in oncology: Focus on radiation therapy. Semin Radiat Oncol 18, 136-148 (2008)
  • Okamura N, Furumoto S, Arai H, Iwata R, Yanai K, Kudo Y. Imaging and amyloid pathology in the living brain. Curr Med Imaging Rev 4, 56-62 (2008)
  • Pappata S, Salvatore E, Postiglione A. In vivo imaging of neurotransmission and brain receptors in dementia. J Neuroimaging 18, 111-124 (2008)
  • Piert M, Carey J, Clinthorne N. Probe-guided localization of cancer deposits using [18F]fluorodeoxyglucose. Q J Nucl Med Mol Imaging 52, 37-49 (2008)
  • Saraste A, Nekolla S, Schwaiger M. Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability. J Nucl Cardiol 15, 105-117 (2008)
  • Taki J, Matsunari I. Metabolic imaging using SPECT. Eur J Nucl Med Mol Imaging 34, S34-S48 (2007)
  • Tashiro M, Fukuda H, Itoh M, Matsuzawa T, Yanai K. Molecular imaging at Tohoku university: From cancer to neuroreceptors. Curr Med Imaging Rev 4, 8-13 (2008)
  • Tranquart F, Correas JM, Marret H, Portalez D, Bleuzen A. Recent advances in contrast-enhanced ultrasound for oncology applications (French, English Abstract). J Radiol 88, 1759-1769 (2007)
  • Wang L, Van den Bos IC, Hussain SM, Pattynama PM, Vogel MW, Krestin GP. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: Explanation and potential clinical applications for color-coded qualitative and quantitative analysis. Acta Radiol 49, 6-18 (2008)
  • Wolters SL, Corsten MF, Reutelingsperger CPM, Narula J, Hofstra L. Cardiovascular molecular imaging of apoptosis. Eur J Nucl Med Mol Imaging 34, S86-S98 (2007)
  • Yamashina S, Yamazaki JI. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 34, S62-S73 (2007)
  • Yang DJ, Chanda M, Sims-Mourtada J, Azhdarinia A, Chang S, Bryant J, Kim EE. Challenges and opportunities in molecular imaging. Curr Med Imaging Rev 4, 46-50 (2008)
  • Yazyev OV, Helm L. Nuclear spin reaction parameters of MRI contrast agents - Insight from quantum mechanical calculations. Eur J Inorg Chem 201-211 (2008)
  • Zhang LM, Bhojani MS, Ross BD, Rehemtulla A. Molecular imaging of protein kinases. Cell Cycle 7, 314-317 (2008)
  • Contrast Agents: 3. Chemistry
  • Borel A, Bean JF, Clarkson RB, Helm L, Moriggi L, Sherry AD, Woods M. Towards the rational design of MRI contrast agents: Electron spin relaxation is largely unaffected by the coordination geometry of gadolinium(III)-DOTA-type complexes. Chem Eur J 14, 2658-2667 (2008)
  • Cai WB, Chen XY. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nat Protoc 3, 89-96 (2008)
  • Cilliers R, Song Y, Kohlmeir EK, Larson AC, Omary RA, Meade TJ. Modification of embolic-PVA particles with MR contrast agents. Magn Reson Med 59, 898-902 (2008)
  • Clarke SJ, Hollmann CA, Aldaye FA, Nadeau JL. Effect of ligand density on the spectral, physical, and biological characteristics of CdSe/ZnS quantum dots. Bioconjug Chem 19, 562-568 (2008)
  • Datta A, Hooker JM, Botta M, Francis MB, Aime S, Raymond KN. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: Nanosized MRI contrast agents. J Am Chem Soc 130, 2546-2552 (2008)
  • Giri J, Pradhan P, Somani V, Chelawat H, Chhatre S, Banerjee R, Bahadur D. Synthesis and characterizations of water-based ferrofluids of substituted ferrites [Fe1-xBxFe2O4, B = Mn, Co (x = 0-1)] for biomedical applications. J Magn Magn Mater 320, 724-730 (2008)
  • Guo SR, Gong JY, Jiang P, Wu M, Lu Y, Yu SH. Biocompatible, luminescent silver@phenol formaldehyde resin core/shell nanospheres: Large-scale synthesis and application for in vivo bioimaging. Adv Funct Mater 18, 872-879 (2008)
  • Henoumont C, Henrotte V, Laurent S, Vander Elst L, Muller RN. Synthesis of a new gadolinium complex with a high affinity for human serum albumin and its manifold physicochemical characterization by proton relaxation rate analysis, NMR diffusometry and electrospray mass spectrometry. J Inorg Biochem 102, 721-730 (2008)
  • Kamaly N, Kalber T, Ahmad A, Oliver MH, So PW, Herlihy AH, Bell JD, Jorgensen MR, Miller AD. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug Chem 19, 118-129 (2008)
  • Koullourou T, Natrajan LS, Bhavsar H, Pope SJA, Feng JH, Narvainen J, Shaw R, Scales E, Kauppinen R, Kenwright AM, Faulkner S. Synthesis and spectroscopic properties of a prototype single molecule dual imaging agent comprising a heterobimetallic rhenium-gadolinium complex. J Am Chem Soc 130, 2178-2179 (2008)
  • Lee HY, Lee SH, Xu CJ, Xie J, Lee JH, Wu B, Koh AL, Wang XY, Sinclair R, Wang SX, Nishimura DG, Biswal S, Sun SH, Cho SH, Chen XY. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 19, 165101 (2008)
  • Lee YT, Woo K, Choi KS. Preparation of water-dispersible and biocompatible iron oxide nanoparticles for MRI agent. IEEE Trans Nanotechnol 7, 111-114 (2008)
  • Li WS, Li ZF, Jing FY, Deng YF, Wei L, Liao P, Yang XG, Li XJ, Pei FK, Wang XX, Lei H. Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents. Carbohydr Res 343, 685-694 (2008)
  • Livramento JB, Helm L, Sour A, O'Neil C, Merbach AE, Toth E. A benzene-core trinuclear Gd-III complex: Towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Dalton Trans 1195-1202 (2008)
  • Lucas RL, Benjamin M, Reineke TM. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate. Bioconjug Chem 19, 24-27 (2008)
  • Maenosono S, Suzuki T, Saita S. Superparamagnetic FePt nanoparticles as excellent MRI contrast agents (Letter). J Magn Magn Mater 320, L79-L83 (2008)
  • Mishra A, Fouskova P, Angelovski G, Balogh E, Mishra AK, Logothetis NK, Toth E. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: An attempt towards calcium-sensitive MRI contrast agents. Inorg Chem 47, 1370-1381 (2008)
  • Park JA, Lee JJ, Kim IS, Park BH, Lee GH, Kim TJ, Ri HC, Kim HJ, Chang YM. Magnetic and MR relaxation properties of avidin-biotin conjugated superparamagnetic nanoparticles. Colloid Surface A 313-314, 288-291 (2008)
  • Patel D, Moon JY, Chang YM, Kim TJ, Lee GH. Poly(D,L-lactide-co-glycolide) coated superparamagnetic iron oxide nanoparticles: Synthesis, characterization and in vivo study as MRI contrast agent. Colloid Surface A 313-314, 91-94 (2008)
  • Seo SB, Yang J, Lee TI, Chung CH, Song YJ, Suh JS, Yoon HG, Huh YM, Haam S. Enhancement of magnetic resonance contrast effect using ionic magnetic clusters. J Colloid Interface Sci 319, 429-434 (2008)
  • Shu CY, Wang CR, Zhang JF, Gibson HW, Dorn HC, Corwin FD, Fatouros PP, Dennis TJS. Organophosphonate functionalized Gd@C82 as a magnetic resonance imaging contrast agent. Chem Mater 20, 2106-2109 (2008)
  • Stavila V, Allali M, Canaple L, Stortz Y, Franc C, Maurin P, Beuf O, Dufay O, Samarut J, Janier M, Hasserodt J. Significant relaxivity gap between a low-spin and a high-spin iron(II) complex of structural similarity: An attractive off-on system for the potential design of responsive MRI probes. New J Chem 32, 428-435 (2008)
  • Taylor KML, Kim JS, Rieter WJ, An H, Lin WL, Lin WB. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 130, 2154-2155 (2008)
  • Xu CJ, Xie J, Kohler N, Walsh EG, Chin YE, Sun SH. Monodisperse magnetite nanoparticles coupled with nuclear localization signal peptide for cell-nucleus targeting. Chem Asian J 3, 548-552 (2008)
  • 4. Technique
  • Babos M, Schwarcz A, Randhawa MS, Marton B, Kardos L, Palko A. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract. Eur J Radiol 65, 133-139 (2008)
  • Berkova Z, Jirak D, Zacharovova K, Kriz J, Lodererova A, Girman P, Koblas T, Dovolilova E, Vancova M, Hajek M, Saudek F. Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance. Transplantation 85, 155-159 (2008)
  • Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29, 597-606 (2008)
  • Briley-Saebo KC, Mani V, Hyafil F, Cornily JC, Fayad ZA. Fractionated Feridex and positive contrast: In vivo MR imaging of atherosclerosis. Magn Reson Med 59, 721-730 (2008)
  • Bunyaviroch T, Turkington TG, Wong TZ, Wilson JW, Colsher JG, Coleman RE. Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements. Mol Imaging Biol 10, 107-113 (2008)
  • Cornelissen SA, Verhagen HJ, Prokop M, Moll FL, Bartels LW. Visualizing type IV endoleak using magnetic resonance imaging with a blood pool contrast agent. J Vasc Surg 47, 861-864 (2008)
  • Cyran CC, Fu YJ, Raatschen HJ, Rogut V, Chaopathomkul B, Shames DM, Wendland MF, Yeh BM, Brasch RC. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues. J Magn Reson Imaging 27, 581-589 (2008)
  • De Lin M, Ning LT, Badea CT, Mistry NN, Qi Y, Johnson GA. A high-precision contrast injector for small animal X-ray digital subtraction angiography. IEEE Trans Biomed Eng 55, 1082-1091 (2008)
  • De Sousa PL, Livramento JB, Helm L, Merbach AE, Meme W, Doan BT, Beloeil JC, Prata MIM, Santos AC, Geraldes CFGC, Toth E. In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications. Contrast Media Mol Imaging 3, 78-85 (2008)
  • Erdogan S, Medarova ZO, Roby A, Moore A, Torchilin VP. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. J Magn Reson Imaging 27, 574-580 (2008)
  • Erturk SM, Ichikawa T, Sou H, Tsukamoto T, Motosugi U, Araki T. Effect of duration of contrast material injection on peak enhancement times and values of the aorta, main portal vein, and liver at dynamic MDCT with the dose of contrast medium tailored to patient weight. Clin Radiol 63, 263-271 (2008)
  • Galema TW, Geleijnse ML, Yap SC, Van Domburg RT, Biagini E, Vletter WB, Ten Cate FJ. Assessment of left ventricular ejection fraction after myocardial infarction using contrast echocardiography. Eur J Echocardiogr 9, 250-254 (2008)
  • Gianolio E, Giovenzana GB, Ciampa A, Lanzardo S, Imperio D, Aime S. A novel method of cellular labeling: Anchoring MR-imaging reporter particles on the outer cell surface. ChemMedChem 3, 60-62 (2008)
  • Greenberg SB, Bhutta ST. A dual contrast injection technique for multidetector computed tomography angiography of Fontan procedures. Int J Cardiovasc Imaging 24, 345-348 (2008)
  • Hirschberg H, Wo GN, Madsen SJ. Evaluation of motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI. Minim Invasive Neurosurg 50, 318-323 (2007)
  • Hoory T, Ramsay E, Plewes DB. Effect of Gd-DTPA induced susceptibility on single-point Dixon fat/water separation. Magn Reson Med 59, 925-929 (2008)
  • Hu HH, Haider CR, Campeau NG, Huston J, Riederer SJ. Intracranial contrast-enhanced magnetic resonance venography with 6.4-fold sensitivity encoding at 1.5 and 3.0 Tesla. J Magn Reson Imaging 27, 653-658 (2008)
  • Jansen SA, Fan XB, Karczmar GS, Abe H, Schmidt RA, Newstead GM. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: A sensitivity and specificity study. Magn Reson Med 59, 747-754 (2008)
  • Kim RJ, Albert TSE, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction - An international, multicenter, double-blinded, randomized trial. Circulation 117, 629-637 (2008)
  • Kuder TA, Risse F, Eichinger M, Ley S, Puderbach M, Kauczor HU, Fink C. New method for 3D parametric visualization of the contrast-enhanced pulmonary perfusion MRI data. Eur Radiol 18, 291-297 (2008)
  • Kustermann E, Himmelreich U, Kandal K, Geelen T, Ketkar A, Wiedermann D, Strecker C, Esser J, Arnhold S, Hoehn M. Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging 3, 27-37 (2008)
  • Li AX, Wojciechowski F, Suchy M, Jones CK, Hudson RHE, Merton RS, Bartha R. A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe). Magn Reson Med 59, 374-381 (2008)
  • Liu W, Dahnke H, Jordan EK, Schaeffter T, Frank JA. In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed 21, 242-250 (2008)
  • Marklund M, Torp-Pedersen S, Bentzon N, Thomsen C, Roslind A, Nolsoe CR. Contrast kinetics of the malignant breast tumour - Border versus centre enhancement on dynamic midfield MRI. Eur J Radiol 65, 279-285 (2008)
  • Natarajan A, Xiong CY, Gruettner C, DeNardo GL, DeNardo SJ. Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. Cancer Biother Radiopharm 23, 82-91 (2008)
  • Palmowski M, Morgenstern B, Hauff P, Reinhardt M, Huppert J, Maurer M, Woenne EC, Doerk S, Ladewig G, Jenne JW, Delorme S, Grenacher L, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F. Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol 43, 162-169 (2008)
  • Park IK, Ng CP, Wang J, Chu B, Yuan C, Zhang S, Pun SH. Determination of nanoparticle vehicle unpackaging by MR imaging of a T2 magnetic relaxation switch. Biomaterials 29, 724-732 (2008)
  • Regino CAS, Walbridge S, Bernardo M, Wong KJ, Johnson D, Lonser R, Oldfield EH, Choyke PL, Brechbiel MW. A dual CT-MR dendrimer contrast agent as a surrogate marker for convention-enhanced delivery of intracerebral macromolecular therapeutic agents. Contrast Media Mol Imaging 3, 2-8 (2008)
  • Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging - Effect of a higher initial enhancement thresholds on diagnostic performance. Invest Radiol 43, 236-242 (2008)
  • Stafford RB, Sabati M, Mahallati H, Frayne R. 3D non-contrast-enhanced MR angiography with balanced steady-state free precession Dixon method. Magn Reson Med 59, 430-433 (2008)
  • Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER, Ferrara KW. Imaging of angiogenesis using Cadence™ contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 3, 9-18 (2008)
  • Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson J, Zhang M. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 4, 372-379 (2008)
  • Tasciotti E, Liu XW, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MMC, Decuzzi P, Tour JM, Robertson F, Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 3, 151-157 (2008)
  • Vos PC, Hambrock T, Hulsbergen-van de Kaa CA, Futterer JJ, Barentsz JO, Huisman HJ. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Med Phys 35, 888-899 (2008)
  • Votaw JR, Martin D. Modeling systemic and renal gadolinium chelate transport with MRI. Pediatr Radiol 38, S28-S34 (2008)
  • Wang T, Hossann M, Reinl HM, Peller M, Eibl H, Reiser M, Issels RD, Lindner LH. In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated 1H MR T1-shortening gadodiamide. Contrast Media Mol Imaging 3, 19-26 (2008)
  • Yanaga Y, Awai K, Nakaura T, Namimoto T, Oda S, Funama Y, Yamashita Y. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. Am J Roentgenol 190, 1003-1009 (2008)
  • Yigit MV, Mazumdar D, Lu Y. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles. Bioconjug Chem 19, 412-417 (2008)
  • Yrjana SK, Vaara T, Karttunen A, Koivukangas J. Pulse repetition time and contrast enhancement -Simulation study of Gd-BOPTA and conventional contrast agent at different field strengths. Invest Radiol 43, 267-275 (2008)
  • Zhu WL, Okollie B, Bhujwalla ZM, Artemov D. PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn Reson Med 59, 679-685 (2008)
  • 5. Experimental
  • Bramos D, Tsirikos N, Kottis G, Pamboucas C, Kostopoulou V, Trika C, Ikonomidis I, Toumanidis S. The acute effect of an echo-contrast agent on right ventricular dimensions and contractility in pigs. J Cardiovasc Pharmacol 51, 86-91 (2008)
  • Cai J, Zhang X, Wang X, Li C, Liu G. In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection. Contrast Media Mol Imaging 3, 72-77 (2008)
  • Chamberland DL, Agarwal A, Kotov N, Fowlkes JB, Carson PL, Wang X. Photoacoustic tomography of joints aided by an etanercept-conjugated gold nanoparticle contrast agent - An ex vivo preliminary rat study. Nanotechnology 19, 095101 (2008)
  • Elmstahl B, Nyman U, Leander P, Golman K, Chai CM, Grant D, Doughty R, Pehrson R, Bjork J, Almen T. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: Arteriography in ischemic porcine kidneys. Radiology 247, 88-97 (2008)
  • Hsu YH, Chen CCV, Zechariah A, Yen CC, Yang LC, Chang C. Neuronal dysfunction of a long projecting multisynaptic pathway in response to methamphetamine using manganese-enhanced MRI. Psychopharmacology (Berl) 196, 543-553 (2008)
  • Kerl JM, Nguyen SA, Lazarchick J, Powell JW, Oswald MW, Alvi F, Costello P, Vogl TJ, Schoepf UJ. Iodinated contrast media: Effect of osmolarity and injection temperature on erythrocyte morphology in vitro. Acta Radiol 49, 337-343 (2008)
  • Krishnan AS, Neves AA, De Backer MM, Hu DE, Davletov B, Kettunen MI, Brindle KM. Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology 246, 854-862 (2008)
  • Kwack KS, Cho JH, Kim MS, Yoon CS, Yoon YS, Choi JW, Kwon JW, Min BH, Sun JS, Kim SY. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model. Acta Radiol 49, 65-74 (2008)
  • Lee SH, Suh JS, Shin MJ, Kim SM, Kim N, Suh SH. Quantitative assessment of synovial vascularity using contrast-enhanced power Doppler ultrasonography: Correlation with histologic findings and MR imaging findings in arthritic rabbit knee model. Korean J Radiol 9, 45-53 (2008)
  • Mistry NN, Pollaro J, Song JY, De Lin M, Johnson GA. Pulmonary perfusion imaging in the rodent lung using dynamic contrast-enhanced MRI. Magn Reson Med 59, 289-297 (2008)
  • Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis - MRI assessment. Arterioscler Thromb Vasc Biol 28, 265-271 (2008)
  • Mule S, De Cesare A, Lucidarme O, Frouln F, Herment A. Attenuation estimation for contrast enhanced ultrasound in small animal studies (French, English Abstract). J Radiol 88, 1770-1776 (2007)
  • Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): Colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 68, 129-137 (2008)
  • Ribot EJ, Thiaudiere E, Roulland R, Brugieres P, Rahmouni A, Voisin P, Franconi JM, Miraux S. Application of MRI phase-difference mapping to assessment of vascular concentrations of BMS agent in mice. Contrast Media Mol Imaging 3, 64-71 (2008)
  • Sato H, Enmi J, Teramoto N, Hayashi T, Yamamoto A, Tsuji T, Naito H, Iida H. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging. Acta Radiol 49, 172-179 (2008)
  • Schipper ML, Cheng Z, Lee SW, Bentolila LA, Iyer G, Rao JH, Chen XY, Wul AM, Weiss S, Gambhirl SS. MicroPET-based biodistribution of quantum dots in living mice. J Nucl Med 48, 1511-1518 (2007)
  • Shetty AN, Bis KG, Vyas AR, Kumar A, Anderson A, Balasubramaniam M. Contrast volume reduction with superior vena cava catheter-directed coronary CT angiography: Comparison with peripheral IV contrast enhancement in a swine model. Am J Roentgenol 190, W247-W254 (2008)
  • Su JF, Zhang J, Liu L, Huang YL, Mason RP. Exploring feasibility of multicolored CdTe quantum dots for in vitro and in vivo fluorescent imaging. J Nanosci Nanotechnol 8, 1174-1177 (2008)
  • Suckow CE, Stout DB. MicroCT liver contrast agent enhancement over time, dose, and mouse strain. Mol Imaging Biol 10, 114-120 (2008)
  • Terreno E, Delli Castelli D, Milone L, Rollet S, Stancanello J, Violante E, Aime S. First ex-vivo MRI co-localization of two LIPOCREST agents. Contrast Media Mol Imaging 3, 38-43 (2008)
  • Terrovitis J, Stuber M, Youssef A, Preece S, Leppo M, Kizana E, Schar M, Gerstenblith G, Weiss RG, Marban E, Abraham MR. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117, 1555-1562 (2008)
  • Torres S, Prata MIM, Santos AC, Andre JP, Martins JA, Helm L, Toth E, Garcia-Martin ML, Rodrigues TB, Lopez-Larrubia P, Cerdan S, Geraldes CFGC. GdIII-EPTPAC16, a new self-assembling potential liver MRI contrast agent: In vitro characterization and in vivo animal imaging studies. NMR Biomed 21, 322-336 (2008)
  • Wang J, Liu HY, Lv H, Xiang B, Gruwel M, Tomanek B, Deslauriers R, Tian GH. Identification of chronic myocardial infarction with extracellular or intravascular contrast agents in magnetic resonance imaging. Acta Pharmacol Sin 29, 65-73 (2008)
  • Wu SH, Lin YS, Hung Y, Chou YH, Hsu YH, Chang C, Mou CY. Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies. Chembiochem 9, 53-57 (2008)
  • Wu X, Hu J, Zhou LF, Mao Y, Yang B, Gao L, Xie R, Xu F, Zhang D, Liu J, Zhu J. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. J Neurosurg 108, 320-329 (2008)
  • Yasuda S, Ikuta K, Uwatoku T, Oi K, Abe K, Hyodo F, Yoshimitsu K, Sugimura K, Utsumi H, Katayama Y, Shimokawa H. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice. J Vasc Res 45, 123-128 (2008)
  • 6. Applications
  • Ergen FB, Akata D, Sarikaya B, Kerimoglu U, Hayran M, Akhan O, Hussain HK. Visualization of the biliary tract using gadobenate dimeglumine: Preliminary findings. J Comput Assist Tomogr 32, 54-60 (2008)
  • Ickenstein GW, Valaikiene J, Koch H, Hau P, Erban P, Schlachetzki F. Ultrasonic contrast agents in transcranial perfusion (TPS) for follow-up of patients with high grade sonography gliomas. Ultrason Sonochemistry 15, 510-516 (2008)
  • McGregor R, Vymazal J, Martinez-Lopez M, Neuwirth J, Salgado P, Beregi JP, Peduto A, De la Pena-Almaguer E, Slater GJ, Shamsi K, Parsons EC. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. Eur J Radiol 65, 316-325 (2008)
  • Mori K, Shiigai M, Ueda T, Kita N, Tanaka N, Minarni M. Assessment of the uterine artery before uterine arterial embolization: Comparison of unenhanced 3D water-excitation sensitivity-encoding time-of-flight (WEST) and gadolinium-enhanced 3D sensitivity-encoding water-excitation multishot echo-planar (SWEEP) MR angiography. J Magn Reson Imaging 27, 557-562 (2008)
  • Naganawa S, Satake H, Iwano S, Kawai H, Kubota S, Komada T, Kawamura M, Sakurai Y, Fukatsu H. Contrast-enhanced MR imaging of the brain using T1-weighted FLAIR with BLADE compared with a conventional spin-echo sequence. Eur Radiol 18, 337-342 (2008)
  • Toso C, Valle JP, Morel P, Ris F, Demuylder-Mischler S, Lepetit-Coiffe M, Marangon N, Saudek F, James Shapiro AM, Bosco D, Berney T. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 8, 701-706 (2008)
  • Molecular Imaging: 7. Carbon
  • Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem 51, 17-30 (2008)
  • Cai LS, Liow JS, Zoghbi SS, Cuevas J, Baetas C, Hong J, Shetty HU, Seneca NM, Brown AK, Gladding R, Temme SS, Herman MM, Innis RB, Pike VW. Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4′-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging β-amyloid plaques in Alzheimer's disease. J Med Chem 51, 148-158 (2008)
  • Conti PS, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. In vivo measurement of cell proliferation in canine brain tumor using 11C-labeled FMAU and PET. Nucl Med Biol 35, 131-141 (2008)
  • De Vries EFJ, Doorduin J, Dierckx RA, Van Waarde A. Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl Med Biol 35, 35-42 (2008)
  • Fuchigami T, Haradahira T, Fujimoto N, Okauchi T, Maeda J, Suzuki K, Suhara T, Yamamoto F, Sasaki S, Mukai T, Yamaguchi H, Ogawa M, Magata Y, Maeda M. Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel. Nucl Med Biol 35, 203-212 (2008)
  • Gao M, Wang M, Zheng QH. Synthesis of carbon-11 labeled 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolinium derivatives as new potential PET SKCa channel imaging agents. Appl Radiat Isot 66, 194-202 (2008)
  • Herrero P, Dence CS, Coggan AR, Kisrieva-Ware Z, Eisenbeis P, Gropler RJ. L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: A feasibility study. J Nucl Med 48, 2046-2055 (2007)
  • Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage 39, 1289-1298 (2008)
  • Jacobson O, Mishani E. [11C]-Dimethylamine as a labeling agent for PET biomarkers. Appl Radiat Isot 66, 188-193 (2008)
  • Lee HS, Kim MK, Lee C, Kim J, Choo IH, Woo JI, Chong Y. Chemometric studies on brain-uptake of PET agents via VolSurf analysis. Bull Korean Chem Soc 29, 61-68 (2008)
  • McCormick PN, Kapur S, Seeman P, Wilson AA. Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H]raclopride are indistinguishably inhibited by D2 agonists and angonists ex vivo. Nucl Med Biol 35, 11-17 (2008)
  • Merritt ME, Harrison C, Storey C, Jeffrey FM, Sherry AD, Malloy CR. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A 104, 19773-19777 (2007)
  • Morita M, Sone T, Yamatsugu K, Solitome Y, Matsunaga S, Kanaia M, Watanabe Y, Shibasaki M. A method for the synthesis of an oseltamivir PET tracer. Bioorg Med Chem Lett 18, 600-602 (2008)
  • Mourik JEM, Lubberink M, Klumpers UMH, Comans EF, Lammertsma AA, Boellaard R. Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C] flumazenil. Neuroimage 39, 1041-1050 (2008)
  • Nabuurs CIHC, Klomp DWJ, Veltien A, Kan HE, Heerschap A. Localized sensitivity enhanced in vivo13C MRS to detect glucose metabolism in the mouse brain. Magn Reson Med 59, 626-630 (2008)
  • Sakata M, Kimura Y, Naganawa M, Ishikawa M, Oda K, Ishii K, Hashimoto K, Chihara K, Ishiwata K. Shortened protocol in practical [11C]SA4503-PET studies for σ1 receptor quantification. Ann Nucl Med 22, 143-146 (2008)
  • Schweiger L, Craib S, Welch A, Smith TAD. Synthesis of (E)-2,3′,4,5′-tetramethoxy[2-11C]stilbene. J Label Compound Radiopharm 50, 1206-1210 (2007)
  • Toyohara J, Okada M, Toramatsu C, Suzuki K, Irie T. Feasibility studies of 4′-[methyl-11C]thiothymidine as a tumor proliferation imaging agent in mice. Nucl Med Biol 35, 67-74 (2008)
  • Vas A, Shchukin Y, Karrenbauer VD, Cselenyi Z, Kostulas K, Hillert J, Savic I, Takano A, Halldin C, Gulyas B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J Neurol Sci 264, 9-17 (2008)
  • Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med 49, 327-334 (2008)
  • Zhang MR, Kumata K, Maeda J, Yanamoto K, Hatori A, Okada M, Higuchi M, Obayashi S, Suhara T, Suzuki K. 11C-AC-5216: A novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med 48, 1853-1861 (2007)
  • 8. Fluorine
  • Bradbury MS, Hambardzumyan D, Zanzonico PB, Schwartz J, Cai S, Burnazi EM, Longo V, Larson SM, Holland EC. Dynamic small-animal PET imaging of tumor proliferation with 3′-deoxy-3′-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas. J Nucl Med 49, 422-429 (2008)
  • Brust P, Patt JT, Deuther-Conrad W, Ecker G, Patt M, Schildan A, Sorger D, Kendziorra K, Meyer P, Steinbach J, Sabri O. In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine. Synapse 62, 205-218 (2008)
  • Busk M, Horsman MR, Jakobsen S, Keiding S, Van der Kogel AJ, Bussink J, Overgaard J. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: A comparative study involving micropet, autoradiography, PO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys 70, 1202-1212 (2008)
  • Celen S, Deroose C, De Groot T, Chitneni SK, Gijsbers R, Debyser Z, Mortelmans L, Verbruggen A, Bormans G. Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography. Bioconjug Chem 19, 441-449 (2008)
  • Chin FT, Namavari M, Levi J, Subbarayan M, Ray P, Chen XY, Gambhir SS. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: A novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol 10, 82-91 (2008)
  • Chitneni SK, Garreau L, Cleynhens B, Evens N, Bex M, Vermaelen P, Chalon S, Busson R, Guilloteau D, Van Laere K, Verbruggen A, Bormans G. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [18F] FECT. Nucl Med Biol 35, 75-82 (2008)
  • Deuther-Conrad W, Patt JT, Lockman PR, Allen DD, Patt M, Schildan A, Ganapathy V, Steinbach J, Sabri O, Brust P. Norchloro-fluoro-homoepibatidine (NCFHEB) - A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET. Eur Neuropsychopharmacol 18, 222-229 (2008)
  • Ferl GZ, Zhang XL, Wu HM, Huang SC. Estimation of the 18FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data. J Nucl Med 48, 2037-2045 (2007)
  • Ghosh P, Gelovani JG, Alauddin MM. N3-Substituted thymidine analogues III: radiosynthesis of N3-[(4-[18F]fluoromethyl-phenyl)butyl]thymidine ([18F]-FMPBT) and N3-[(4-[18F]fluoromethyl-phenyl)pentyl]thymidine ([18F]-FMPPT) for PET. J Label Compound Radiopharm 50, 1185-1191 (2007)
  • Hsu WK, Virk MS, Feeley BT, Stout DB, Chatziloannou AE, Lieberman JR. Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18FDG and 18F-fluoride PET/CT. J Nucl Med 49, 414-421 (2008)
  • Ichise M, Cohen RM, Carson RE. Noninvasive estimation of normalized distribution volume: Application to the muscarinic-2 ligand [18F]FP-TZTP. J Cereb Blood Flow Metab 28, 420-430 (2008)
  • Kesner AL, Hsueh WA, Htet NL, Pio BS, Czernin J, Pegram MD, Phelps ME, Silverman DHS. Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenografts. J Nucl Med 48, 2021-2027 (2007)
  • Koivula T, Majamaki P, Haaparanta M, Fagerholm V, Gronroos T, Lipponen T, Perhola O, Vepsalainen J, Solin O. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2-carbomethoxy-3β-(4-fluorophenyl)nortropane in rats. Nucl Med Biol 35, 177-183 (2008)
  • Kronenberg UB, Drewes B, Sihver W, Coenen HH. N-2-(4-N-(4-[18F]Fluorobenzamido)phenyl)-propyl-2-propanesulphonamide: Synthesis and radiofluorination of a putative AMPA receptor ligand. J Label Compound Radiopharm 50, 1169-1175 (2007)
  • Le Foll B, Chefer SI, Kimes AS, Shumway D, Goldberg SR, Stein EA, Mukhin AG. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380. J Nucl Med 48, 1492-1500 (2007)
  • Li ZB, Wu ZH, Cao QZ, Dick DW, Tseng JR, Gambhir SS, Chen XY. The synthesis of 18F-FDS and its potential application in molecular imaging. Mol Imaging Biol 10, 92-98 (2008)
  • Li ZB, Wu ZH, Chen K, Ryu EK, Chen XY. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging. J Nucl Med 49, 453-461 (2008)
  • Lin ZX, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, Ling CC. The influence of charges in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70, 1219-1228 (2008)
  • Marengo M, Lodi F, Magi S, Cicoria G, Pancaldi D, Boschi S. Assessment of radionuclidic impurities in 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) routine production. Appl Radiat Isot 66, 295-302 (2008)
  • Nejjari M, Kryza D, Poncet G, Roche C, Perek N, Chayvialle JA, Le Bars D, Scoazec JY, Janier M, Borson-Chazot F. In vitro and in vivo studies with [18F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor. Nucl Med Biol 35, 123-130 (2008)
  • Quon A, Chang ST, Chin F, Kamaya A, Dick DW, Loo BW, Gambhir SS, Koong AC. Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer. Eur J Nucl Med Mol Imaging 35, 527-531 (2008)
  • Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: Proof of mechanism. Lancet Neurol 7, 129-135 (2008)
  • Shanab K, Wadsak W, Mien LK, Mitterhauser M, Holzer W, Polster V, Viernstein H, Spreitzer H. Synthesis of in vivo metabolites of the new adenosine A3 receptor PET-radiotracer [18F] FE@SUPPY. Heterocycles 75, 339-356 (2008)
  • Sharkey RM, Karacay H, Vallabhajosula S, McBride WJ, Rossi EA, Chang CH, Goldsmith SJ, Goldenberg DM. Metastatic human colonic carcinoma: Molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology 246, 497-507 (2008)
  • Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH. Differentiation between malignant and benign pathologic fractures with 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Skeletal Radiol 37, 415-421 (2008)
  • Sorger D, Scheunemann M, Grossmann U, Fischer S, Vercouille J, Hiller A, Wenzel B, Roghani A, Schliebs R, Brust P, Sabri O, Steinbach J. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. Nucl Med Biol 35, 185-195 (2008)
  • Sugae S, Suzuki A, Takahashi N, Minamimoto R, Cheng C, Theeraladanon C, Endo I, Togo S, Inoue T, Shimada H. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions. Ann Nucl Med 22, 65-72 (2008)
  • Tehrani OS, Muzik O, Helibrun LK, Douglas KA, Lawhorn-Crews JM, Sun HH, Mangner TJ, Shields AF. Tumor imaging using 1-(2′-deoxy-2′-18F-fluoro-β-D-arabinofuranosyl)thymine and PET. J Nucl Med 48, 1436-1441 (2007)
  • Tietze R, Loeber S, Hubner H, Gmeiner P, Kuwert T, Prante O. Discovery of a dopamine D4 selective PET ligand candidate taking advantage of a click chemistry based REM linker. Bioorg Med Chem Lett 18, 983-988 (2008)
  • Viel T, Kuhnast B, Hinnen F, Boisgard R, Tavitian B, Dolle F. Fluorine-18 labelling of small interfering RNAs (siRNAs) for PET imaging. J Label Compound Radiopharm 50, 1159-1168 (2007)
  • Wadsak W, Mien LK, Shanab K, Ettlinger DE, Haeusler D, Sindelar K, Lanzenberger RR, Spreitzer H, Viernstein H, Keppler BK, Dudczak R, Kletter K, Mitterhauser M. Preparation and first evaluation of [18F]FE@SUPPY: A new PET tracer for the adenosine A3 receptor. Nucl Med Biol 35, 61-66 (2008)
  • Wadsak W, Mien LK, Shanab K, Weber K, Schmidt B, Sindelar KM, Ettlinger DE, Haeusler D, Spreitzer H, Keppler BK, Viernstein H, Dudczak R, Kletter K, Mitterhauser M. Radiosynthesis of the adenosine A3 receptor ligand 5-(2-[18F]fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate ([18F]FE@SUPPY). Radiochim Acta 96, 119-124 (2008)
  • Woo SK, Lee TS, Kim KM, Kim JY, Jung JH, Kang JH, Cheon GJ, Choi CW, Lim SM. Anesthesia condition for 18FDG imaging of lung metastasis tumors using small animal PET. Nucl Med Biol 35, 143-150 (2008)
  • Wu YG. Noninvasive quantification of local cerebral metabolic rate of glucose for clinical application using positron emission tomography and 18F-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 28, 242-250 (2008)
  • Wu ZH, Li ZB, Chen K, Cai WB, He L, Chin FT, Li F, Chen XY. MicroPET of tumor integrin αvβ3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). J Nucl Med 48, 1536-1544 (2007)
  • 9. Gallium
  • Plossl K, Chandra R, Qua WC, Lieberman BP, Kung MP, Zhou R, Huang B, Kung HF. A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl Med Biol 35, 83-90 (2008)
  • Toegel S, Wadsak W, Mien LK, Viernstein H, Kluger R, Eidherr H, Haeusler D, Kletter K, Dudczak R, Mitterhauser M. Preparation and pre-vivo evaluation of no-carrier-added, carrier-added and cross-complexed [68Ga]-EDTMP formulations. Eur J Pharm Biopharm 68, 406-412 (2008)
  • Velikyan I, Maecke H, Langstrom B. Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature. Bioconjug Chem 19, 569-573 (2008)
  • 11. Indium
  • Cornelissen B, McLarty K, Kersemans V, Scollard DA, Reilly RA. Properties of [111In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection. Nucl Med Biol 35, 101-110 (2008)
  • Jia F, Figueroa SD, Gallazzi F, Balaji BS, Hannink M, Lever SZ, Hoffman TJ, Lewis MR. Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates. J Nucl Med 49, 430-438 (2008)
  • Li L, Bading J, Yazaki PJ, Ahuja AH, Crow D, Colcher D, Williams LE, Wong JYC, Raubitschek A, Shively JE. A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with 111In and 64Cu at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies. Bioconjug Chem 19, 89-96 (2008)
  • Miao Y, Gallazzi F, Guo H, Quinn TP. 111In-labeled lactam bridge-cyclized α-melanocyte stimulating hormone peptide analogues for melanoma imaging. Bioconjug Chem 19, 539-547 (2008)
  • Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 48, 1501-1510 (2007)
  • 12. Iodine
  • Akhter N, Shiba K, Ogawa K, Tsuji S, Kinuya S, Nakajima K, Mori H. A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for σ receptor imaging. Nucl Med Biol 35, 29-34 (2008)
  • Bois F, Baldwin RM, Amici L, Al-Tikriti MS, Kula N, Baldessarini R, Innis RB, Staley JK, Tamagnan GD. Synthesis, radiolabeling and baboon SPECT imaging of 2β-carbomethoxy-3β-(3′-[123I]iodophenyl)tropane ([123I]YP256) as a serotonin transporter radiotracer. Nucl Med Biol 35, 53-59 (2008)
  • Chaturvedi R, Heimburg J, Yan J, Koury S, Sajjad M, Abdel-Nabi HH, Rittenhouse-Olson K. Tumor immunolocalization using 124I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich α-linked antigen. Appl Radiat Isot 66, 278-287 (2008)
  • Kiyono Y, Sugita T, Ueda M, Kawashima H, Kanegawa N, Kuge Y, Fujibayashi Y, Saji H. Evaluation of radioiodinated (2SS)-2-(α-(2-iodophenoxy)benzyl) morpholine as a radioligand for imaging of norepinephrine transporter in the heart. Nucl Med Biol 35, 213-218 (2008)
  • Lakshmi B, Kung MP, Lieberman B, Zhao J, Waterhouse R, Kung HF. (R)-N-Methyl-3-(3-125I-pyridin-2-yloxy)-3-phenylpropan-1-amine: A novel probe for norepinephrine transporters. Nucl Med Biol 35, 43-52 (2008)
  • Muftuler FZB, Unak P, Teksoz S, Acar C, Yolcular S, Yurekli Y. 131I labeling of tamoxifen and biodistribution studies in rats. Appl Radiat Isot 66, 178-187 (2008)
  • Ricci D, Mennander AA, Pham LD, Rao VP, Miyagi N, Byrne GW, Russell SJ, McGregor CGA. Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts. Eur J Cardiothorac Surg 33, 32-39 (2008)
  • Song PJ, Bernard S, Sarradin P, Vergote J, Barc C, Chalon S, Kung MP, Kung HF, Guilloteau D. IMPY, a potential β-amyloid imaging probe for detection of prion deposits in scrapie-infected mice. Nucl Med Biol 35, 197-201 (2008)
  • Svecova H, Kleinova V, Selfert D, Chaloupkova H, Baurle J, Kranda K, Kral V, Fiser M. Radioiodination of mouse anti-III β-tubulin antibodies and their evaluation with respect to their use as diagnostic agents for peripheral neuropathies. Appl Radiat Isot 66, 310-316 (2008)
  • 14. Technetium
  • Boschi A, Pasquali M, Uccelli L, Duatti A. Novel 99mTc radiotracers for brain imaging. Braz Arch Biol Technol 50, 37-44 (2007)
  • Kim S, Jeong JM, Hong MK, Jang JJ, Lee J, Lee DS, Chung JK, Lee MC. Differential receptor targeting of liver cells using 99mTc-neoglycosylated human serum albumins. Arch Pharm Res 31, 60-66 (2008)
  • Liu S, Kim YS, Hsieh WY, Gupta Sreerama S. Coligand effects on the solution stability, biodistribution and metabolism of the 99mTc-labeled cyclic RGDfK tetramer. Nucl Med Biol 35, 111-121 (2008)
  • Liu ZL, Okada DR, Johnson G, Hocherman SD, Beju D, Okada RD. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model. Eur J Nucl Med Mol Imaging 35, 570-578 (2008)
  • Lu J, Kong DJ, Jia HM, Deuther-Conrad W, Brust P, Wang XB. Preparation and biological evaluation of 99mTcN-4-(cyclohexylpiperazin-1-yl)-dithioformate as a potential σ receptor imaging agent. J Label Compound Radiopharm 50, 1200-1205 (2007)
  • Mirtschink P, Stehr SN, Pietzsch HJ, Bergmann R, Pietzsch J, Wunderlich G, Heintz AC, Kropp J, Spies H, Kraus W, Deussen A, Walther M. Modified “4+1” mixed ligand technetium-labeled fatty acids for myocardial imaging: Evaluation of myocardial uptake and biodistribution. Bioconjug Chem 19, 97-108 (2008)
  • Papathanasiou ND, Rondogianni PE, Pianou NK, Karampina PA, Vlontzou EA, Datseris LE. 99mTc-depreotide in the evaluation of bone infection and inflammation. Nucl Med Commun 29, 239-246 (2008)
  • Satpati D, Bapat K, Sarma HD, Kothari K, Venkatesh M, Banerjee S. Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for σ receptors. Cancer Biother Radiopharm 23, 34-42 (2008)
  • Tadehara F, Yamamoto H, Tsujiyama S, Hinoi T, Matsuo S, Matsumoto N, Sato Y, Kohno N. Feasibility of a rapid protocol of 1-day single-isotope rest/adenosine stress 99mTc sestamibi ECG-gated myocardial perfusion imaging. J Nucl Cardiol 15, 35-41 (2008)
  • Unak P, Teksoz S, Muftuler FZB, Medine EI, Acar C, Yurekli Y. 99mTc-glucoheptonate-guanine: Synthesis, biodistribution and imaging in animals. J Radioanal Nucl Chem 275, 379-385 (2008)
  • Wei IC, Tsao N, Huang YH, Ho YS, Wu CC, Yu DF, Yang DJ. 99mTc-glycopeptide: Synthesis, biodistribution and imaging in breast tumor-bearing rodents. Appl Radiat Isot 66, 320-331 (2008)
  • Yang XJ, He YM, Wu YW, Zhang B, Hui J, Jiang TB, Song JP, Liu ZH, Jiang WP. Hypoxia imaging of patients with acute myocardial infarction by using dual isotopes of 201Tl and 99mTc-HL91. Nucl Med Commun 29, 230-238 (2008)
  • 15. Others
  • Cai WB, Chen K, Li ZB, Gambhir SS, Chen XY. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48, 1862-1870 (2007)
  • Daraban L, Abbas K, Simonelli F, Adam-Rebeles R, Gibson N. Experimental study of excitation functions for the deuteron induced reactions 64Zn(d,2p)64Cu and 64Zn(d,αn)61Cu using the stacked-foil technique. Appl Radiat Isot 66, 261-264 (2008)
  • Edwards WB, Xu B, Akers W, Cheney PP, Liang K, Rogers BE, Anderson CJ, Achilefu S. Agonist-antagonist dilemma in molecular imaging: Evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem 19, 192-200 (2008)
  • Niu G, Cai WB, Chen K, Chen XY. Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor. Mol Imaging Biol 10, 99-106 (2008)
  • Rodriguez-Porcel M, Brinton TJ, Chen IY, Gheysens O, Lyons J, Ikeno F, Willmann JK, Wu L, Wu JC, Yeung AC, Yock P, Gambhir SS. Reporter gene imaging following percutaneous delivery in swine - Moving toward clinical applications (Letter). J Am Coll Cardiol 51, 595-597 (2008)
  • Sato M. Genetically encoded fluorescent indicators to visualize molecular processes in living cells. Bull Chem Soc Jpn 81, 183-192 (2008)
  • Szent-Gyorgyi C, Schmidt BA, Creeger Y, Fisher GW, Zakel KL, Adler S, Fitzpatrick JAJ, Woolford CA, Yan Q, Vasilev KV, Berget PB, Bruchez MP, Jarvik JW, Waggoner A. Fluorogen-activating single-chain antibodies for imaging cell surface proteins. Nat Biotechnol 26, 235-240 (2008)
  • Tanisaka H, Kizaka-Kondoh S, Makino A, Tanaka S, Hiraoka M, Kimura S. Near-infrared fluorescent labeled peptosome for application to cancer imaging. Bioconjug Chem 19, 109-117 (2008)
  • Tian XB, Aruva MR, Zhang KJ, Shanthly N, Cardi CA, Thakur ML, Wickstrom E. PET imaging of CCND1 mRNA in human MCF7 estrogen receptor-positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes. J Nucl Med 48, 1699-1707 (2007)
  • Willmann JK, Chen K, Wang H, Paulmurugan R, Rollins M, Cai W, Wang DS, Chen IY, Gheysens O, Rodriguez-Porcel M, Chen X, Gambhir SS. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 117, 915-922 (2008)
  • Wong TZ, Lacy JL, Petry NA, Hawk TC, Sporn TA, Dewhirst MW, Vlahovic G. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator. Am J Roentgenol 190, 427-432 (2008)
  • Yazaki PJ, Kassa T, Cheung CW, Crow DM, Sherman MA, Bading JR, Anderson ALJ, Colcher D, Raubitschek A. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein. Nucl Med Biol 35, 151-158 (2008)
  • Zhang Y, Phillips GJ, Yeung ES. Quantitative imaging of gene expression in individual bacterial cells by chemiluminescence. Anal Chem 80, 597-605 (2008)